FDA rushed to approve 48 drugs in 2019, sometimes way ahead of schedule. Could that be dangerous?

FDA rushed to approve 48 drugs in 2019, sometimes way ahead of schedule. Could that be dangerous?

Source: 
Endpoints
snippet: 

While the roster of 48 drugs the FDA approved in 2019 didn’t break any records with the sheer number, it was remarkable in one aspect: The agency reached deep into a group of therapies they didn’t need to make a decision on until later this year, in some cases speeding drugs up by months ahead of even priority review deadlines.